Creatine for Brains, Not Biceps: The Mood Molecule in Early Testing

Key takeaways

• Creatine has shown promising mood‑lifting effects in two randomized trials when added to standard approaches like talk‑based support or commonly used mood‑related medications.
• Three other trials—including in people whose mood hadn’t improved with usual care, younger participants, and those with pronounced mood swings—did not show meaningful benefits over placebo.
• Overall, creatine looks like a safe and intriguing candidate, but larger and longer studies are needed before anyone can confidently recommend it for mood support.

Rather than running a new experiment, researchers gathered what’s already out there: six published reports covering five randomized trials of creatine versus placebo in people struggling with mood. The work came from several countries and included a little over two hundred participants in total, with roughly half assigned to creatine and half to placebo. Most participants were women, and two of the trials enrolled women only.

Some studies combined creatine with talking‑based support. Others added it on top of commonly used mood‑related medications. Because the designs, dosages, and outcome measures varied, the researchers didn’t lump the data into one big number. Instead, they examined each trial on its own, asking a simple question: did adding creatine give any extra lift in mood beyond what the usual care provided?

Where creatine seemed to help—and where it didn’t

The clearest encouraging signal came from two studies in women. In one, participants took five grams of creatine daily alongside a standard mood‑related medication. After several weeks, those on creatine showed bigger drops in questionnaire scores that track sadness, lack of interest, and related symptoms, and more of them reached a state that researchers defined as “recovered,” compared with the group receiving medication plus placebo. A second trial found that adding creatine to talking‑based support led to more improvement than the same support plus placebo, again in women.

The other trials told a cooler story. In people whose mood hadn’t improved with usual treatments, neither five nor ten grams of creatine per day produced clear extra gains. Work in younger girls testing different doses similarly failed to show a benefit over placebo. And in individuals with a history of mood swings, creatine did not improve overall mood scores—and a couple of people shifted into an unusually “up” state, prompting concern that creatine might have different effects in those with more variable mood patterns.

Across studies, side effects were generally mild—things like stomach upset—reinforcing creatine’s reputation as a relatively low‑risk supplement in healthy populations. But the mood‑swing signal is a reminder that “generally safe” doesn’t mean risk‑free in every context.

Why creatine is even on the mood radar

Creatine is best known for helping muscles regenerate ATP, the energy currency of cells, during intense effort. The brain, though, is one of the most energy‑hungry organs in the body, and it uses the same phosphocreatine system to buffer short‑term energy demands. Imaging work has suggested that brain energy handling looks different in people experiencing ongoing low mood, hinting that subtle energy problems might be part of the picture.

There are also clues that creatine can nudge signaling systems like serotonin and dopamine, which play central roles in motivation, reward, and emotional tone. Animal experiments have shown mood‑related behavioral changes with creatine, sometimes with sex‑specific effects, which may help explain why the most encouraging human data so far have come from studies in women.

Still, these are hints, not proof. Mood is shaped by many overlapping pathways—energy, stress hormones, inflammation, sleep, social context—and creatine touches only a slice of that web.

What needs to happen next

The core message from this review is not “take creatine for mood,” but “creatine is interesting enough to study properly.” The existing trials are small, short, and uneven in quality. Some were well‑designed; others had issues with how participants were assigned or how missing data were handled. Most focused on women and ran for only a few weeks, which limits how far the findings can be generalized.

The authors argue for larger, longer trials that include more men and a wider age range, and that follow people beyond the typical eight‑week window. They suggest exploring creatine both on its own and as an add‑on, and testing different doses carefully rather than assuming more is better. Pairing human trials with carefully controlled animal work could also clarify how sex, hormones, and brain energy metabolism interact.

For now, creatine sits in a curious middle ground: widely available, familiar to athletes, biologically plausible for brain energy, but still very early in its story as a possible mood‑support tool. It’s a supplement long associated with building muscle that has stepped quietly into the search for new ways to help people feel better—but it’s not ready to be treated as a mood remedy, and experimenting without professional guidance, especially in people with complex mood patterns, remains a genuine gamble.